The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030
Roots Analysis has done a detailed study on Biologics Fill /Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution andidentifying potential future growth opportunities.
To order this 480+ page report, which features 237 figuresand 267 tables, please visit this link
Key Market Insights
§ Over 115 companies located in various regions across theglobe claim to provide contract fill / finish services for various types ofbiopharmaceutical drug / therapy products
§ The market landscape features a mix of both establishedplayers and new entrants; multiple biologics fill / finish service providersbased in developed geographies have already adopted advanced fill / finishtechnologies
§ Vials represent the most prominentform of packaging used for biopharmaceutical interventions; with increasingdemand for self-administration devices, syringes have also garnered significantattention
§ In fact, to acquire competencies across the value chain,stakeholders have actively invested in expanding their existing infrastructureand capabilities to cater to the evolving needs of both indigenous andinternational clients
§ Over the past six years, the fill /finish services domain has also witnessed significant partnership activity,with companies building strategic business relationships to consolidate theirpositions in the market
§ The outcome of consolidation is evident from ourproprietary competitiveness analysis, based on several relevant parametershighlighting service and supplier strengths
§ Presently, the installed global contract fill / finishcapacity, across various geographies, is estimated to be over 17 million units(in term of packaging containers)
§ The demand for contract fill / finish services forbiologics is expected to increase in the coming years; it is likely thatstakeholders will have to expand their respective capacities to ensureconsistent supply
§ We expect biopharmaceutical developers to continue tooutsource their fill / finish operations in the short to mid-term, resulting inan annualized growth rate of more than 10%
§ In the long-term, the projected opportunity is anticipatedto be well distributed across various types of primary packaging, biologicalinterventions and target disease indications
For more information, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for OutsourcingBiologics-related Operations
3.4. Introduction to ContractManufacturing
3.5. Commonly Outsourced Operations in theBiopharmaceutical Industry
3.5.1. Biologics Fill / Finish Operations
3.6. Basic Guidelines for Selecting a Fill/ Finish Service Provider
3.7. Advantages of Outsourcing Fill / FinishServices
3.8. Risks and Challenges of OutsourcingFill / Finish Operations
4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill / Finish ServiceProviders: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill / FinishFacilities
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Additional Services Offered
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Type of Biologics Filled
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Competitiveness Analysis: BiologicsFill / Finish Service Providers in North America
5.4.1. Companies Offering Fill / FinishServices for Ampoules
5.4.2. Companies Offering Fill / FinishServices for Cartridges
5.4.3. Companies Offering Fill / FinishServices for Syringes
5.4.4. Companies Offering Fill / FinishServices for Vials
5.5. Competitiveness Analysis: Fill /Finish Service Providers in Europe
5.5.1. Companies Offering Fill / FinishServices for Ampoules
5.5.2. Companies Offering Fill / FinishServices for Cartridges
5.5.3. Companies Offering Fill / FinishServices for Syringes
5.5.4. Companies Offering Fill / FinishServices for Vials
5.6. Competitiveness Analysis: Fill /Finish Service Providers of Asia-Pacific
5.6.1. Companies Offering Fill / FinishServices for Ampoules
5.6.2. Companies Offering Fill / FinishServices for Cartridges
5.6.3. Companies Offering Fill / FinishServices for Syringes
5.6.4. Companies Offering Fill / FinishServices for Vials
6. BIOLOGICS FILL / FINISH SERVICEPROVIDERS IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Advanced BioScience Laboratories(ABL)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments
6.2.4. Future Outlook
6.3. Albany Molecular Research (AMRI)
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Financial Information
6.3.4. Recent Developments
6.3.5. Future Outlook
6.4. BioPharma Solutions
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments
6.4.5. Future Outlook
6.5. BioReliance
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments
6.5.5. Future Outlook
6.6. Emergent BioSolutions
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments
6.6.5. Future Outlook
6.7. Patheon
6.7.1. Company Overview
6.7.2. Services Portfolio
6.7.3. Financial Information
6.7.4. Recent Developments
6.7.5. Future Outlook
7. BIOLOGICS FILL / FINISH SERVICEPROVIDERS IN EUROPE: COMPANY PROFILES
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments
7.2.5. Future Outlook
7.3. IDT Biologika
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Recent Developments
7.3.4. Future Outlook
7.4. Lonza
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments
7.4.5. Future Outlook
7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.3. Recent Developments
7.5.4. Future Outlook
7.6. Vetter Pharma
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Recent Developments
7.6.4. Future Outlook
8. BIOLOGICS FILL / FINISH SERVICEPROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
8.1. Chapter Overview
8.2. Biocon
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments
8.2.5. Future Outlook
8.3. ChemPartner
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Recent Developments
8.3.4. Future Outlook
8.4. LuinaBio
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Recent Developments
8.4.4. Future Outlook
8.5. Mycenax Biotech
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.3. Recent Developments
8.5.4. Future Outlook
8.6. Wuxi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments
8.6.4. Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish ServiceProviders: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Type of Service
9.3.4. Analysis by Scale of Operation
9.3.5. Analysis by Type of Biologic
9.3.6. Analysis by Geographical Location
9.3.7. Most Active Players: Analysis by Numberof Partnerships
9.3.8. Service Alliances and Supply Agreements:Analysis by Type of Service
9.3.9. Acquisitions and Mergers: Analysis byType of Service
10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill / Finish ServiceProviders: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging
10.2.4. Analysis by Type of Service
10.2.5. Analysis by Type of Biologic
10.2.6. Analysis by Type of Biologic and Scale ofOperation
10.2.7. Analysis by Geographical Location
10.2.8. Most Active Players: Analysis by Type ofService and Type of Biologic
10.2.9. Expansions in North America: Analysis byType of Service and Type of
Biologic
10.2.10. Expansions in Europe: Analysis by Type ofService and Type of Biologic
10.2.11. Expansions in Asia-Pacific: Analysis by Typeof Service and Type of Biologic
11. CAPACITY ANALYSIS
11.1. ChapterOverview
11.2. Assumptions and Methodology
11.3. GlobalInstalled Fill / Finish Capacity (by Number of Units)
11.3.1. Analysis by Type of Packaging
11.3.2. Analysis by Size of Manufacturer
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill / FinishFacilities
11.4. GlobalInstalled Fill / Finish Capacity (by Volume)
11.4.1. Analysis by Type of Packaging
11.4.2. Analysis by Size of Manufacturer
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill / FinishFacilities
11.5. GlobalInstalled Fill / Finish Capacity for Ampoules (by Number of Units)
11.5.1 Analysis by Size of Manufacturer
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill / FinishFacilities
11.6. GlobalInstalled Fill / Finish Capacity for Ampoules (by Volume)
11.6.1. Analysis by Size of Manufacturer
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill / FinishFacilities
11.7. GlobalInstalled Fill / Finish Capacity for Cartridges (by Number of Units)
11.7.1. Analysis by Size of Manufacturer
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill / FinishFacilities
11.8. GlobalInstalled Fill / Finish Capacity for Cartridges (by Volume)
11.8.1. Analysis by Size of Manufacturer
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill / FinishFacilities
11.9. GlobalInstalled Fill / Finish Capacity for Syringes (by Number of Units)
11.9.1 Analysis by Size of Manufacturer
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill / FinishFacilities
11.10. GlobalInstalled Fill / Finish Capacity for Syringes (by Volume)
11.10.1. Analysis by Size of Manufacturer
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill / FinishFacilities
11.11. GlobalInstalled Fill / Finish Capacity for Vials (by Number of Units)
11.11.1 Analysis by Size of Manufacturer
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill / FinishFacilities
11.12. GlobalInstalled Fill / Finish Capacity for Vials (by Volume)
11.12.1. Analysis by Size of Manufacturer
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill / FinishFacilities
11.13. Conclusion
12. DEMAND ANALYSIS
12.1. ChapterOverview
12.2. Assumptions and Methodology
12.3. GlobalDemand for Biologics Fill / Finish Services
12.3.1. Analysis by Type of Packaging
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Geographical Location
12.4. Demand and Supply Analysis
13. BIOLOGICS MANUFACTURING AND FILL /FINISH: KEY PERFORMANCE INDICATORS
13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill /Finish: Types of Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective
13.2.2. Process and Capability Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective
13.2.3. Market Reputation Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective
13.2.4. Other Important Performance Indicators
13.3.5. Conclusion
14. MARKET SIZING AND OPPORTUNITYANALYSIS
14.1. Chapter Overview
14.2. Forecast Methodology
14.3. Overall Biologics Fill / Finish ServicesMarket, 2019-2030
14.3.1. Biologics Fill / Finish Services Market,2019-2030: Distribution by Type of Packaging
14.3.2. Biologics Fill / Finish Services Market,2019-2030: Distribution by Scale of Operation
14.3.3. Biologics Fill / Finish Services Market,2019-2030: Distribution by Type of Biologic
14.3.4. Biologics Fill / Finish Services Market,2019-2030: Distribution by Therapeutic Area
14.3.5. Biologics Fill / Finish Services Market,2019-2030: Distribution by Geographical Region
14.3.5.1 Biologics Fill / Finish Services Market in NorthAmerica, 2019-2030: Distribution by Countries
14.3.5.2. Biologics Fill / Finish Services Market inNorth America, 2019-2030: Distribution by Type of Packaging
14.3.5.3. Biologics Fill / Finish Services Market inNorth America, 2019-2030: Distribution by Scale of Operation
14.3.5.4. Biologics Fill / Finish Services Market inNorth America, 2019-2030: Distribution by Type of Biologic
14.3.5.5. Biologics Fill / Finish Services Market inNorth America, 2019-2030: Distribution by Therapeutic Area
14.3.5.6. Biologics Fill / Finish Services Market inEurope, 2019-2030: Distribution by Countries
14.3.5.7. Biologics Fill / Finish Services Market inEurope, 2019-2030: Distribution by Type of Packaging
14.3.5.8. Biologics Fill / Finish Services Market inEurope, 2019-2030: Distribution by Scale of Operation
14.3.5.9. Biologics Fill / Finish Services Market inEurope, 2019-2030: Distribution by Type of Biologic
14.3.5.10. Biologics Fill / Finish Services Market inEurope, 2019-2030: Distribution by Therapeutic Area
14.3.5.11. Biologics Fill / Finish Services Market inAsia Pacific, 2019-2030: Distribution by Countries
14.3.5.12. Biologics Fill / Finish Services Market inAsia Pacific, 2019-2030: Distribution by Type of Packaging
14.3.5.13. Biologics Fill / Finish Services Market in AsiaPacific, 2019-2030: Distribution by Scale of Operation
14.3.5.14. Biologics Fill / Finish Services Market inAsia Pacific, 2019-2030: Distribution by Type of Biologic
14.3.5.15. Biologics Fill / Finish Services Market in AsiaPacific, 2019-2030: Distribution by Therapeutic Area
14.4. Biologics Fill / Finish Services Marketfor Ampoules, 2019-2030
14.4.2. Biologics Fill / Finish Services Market forAmpoules, 2019-2030: Distribution by Scale of Operation
14.4.2. Biologics Fill / Finish Services Market forAmpoules, 2019-2030: Distribution by Type of Biologic
14.4.3. Biologics Fill / Finish Services Market forAmpoules, 2019-2030: Distribution by Therapeutic Area
14.4.4. Biologics Fill / Finish Services Market forAmpoules, 2019-2030: Distribution by Geographical Region
14.4.4.1. Biologics Fill / Finish Services Market forAmpoules in North America, 2019-2030: Distribution by Scale of Operation
14.4.4.2. Biologics Fill / Finish Services Market forAmpoules in North America, 2019-2030: Distribution by Type of Biologic
14.4.4.3. Biologics Fill / Finish Services Market forAmpoules in North America, 2019-2030: Distribution by Therapeutic Area
14.4.4.4. Biologics Fill / Finish Services Market forAmpoules in Europe, 2019-2030: Distribution by Scale of Operation
14.4.4.5. Biologics Fill / Finish Services Market forAmpoules in Europe, 2019-2030: Distribution by Type of Biologic
14.4.4.6. Biologics Fill / Finish Services Market forAmpoules in Europe, 2019-2030: Distribution by Therapeutic Area
14.4.4.7. Biologics Fill / Finish Services Market forAmpoules in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.4.4.8. Biologics Fill / Finish Services Market forAmpoules in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.4.4.9. Biologics Fill / Finish Services Market forAmpoules in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.5. Biologics Fill / Finish Services Marketfor Cartridges, 2019-2030
14.5.1. Biologics Fill / Finish Services Market forCartridges, 2019-2030: Distribution by Scale of Operation
14.5.2. Biologics Fill / Finish Services Market forCartridges, 2019-2030: Distribution by Type of Biologic
14.5.3. Biologics Fill / Finish Services Market forCartridges, 2019-2030: Distribution by Therapeutic Area
14.5.4. Biologics Fill / Finish Services Market forCartridges, 2019-2030: Distribution by Geographical Region
14.5.4.1. Biologics Fill / Finish Services Market forCartridges in North America, 2019-2030: Distribution by Scale of Operation
14.5.4.2. Biologics Fill / Finish Services Market forCartridges in North America, 2019-2030: Distribution by Type of Biologic
14.5.4.3. Biologics Fill / Finish Services Market forCartridges in North America, 2019-2030: Distribution by Therapeutic Area
14.5.4.4. Biologics Fill / Finish Services Market forCartridges in Europe, 2019-2030: Distribution by Scale of Operation
14.5.4.5. Biologics Fill / Finish Services Market forCartridges in Europe, 2019-2030: Distribution by Type of Biologic
14.5.4.6. Biologics Fill / Finish Services Market forCartridges in Europe, 2019-2030: Distribution by Therapeutic Area
14.5.4.7. Biologics Fill / Finish Services Market forCartridges in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.5.4.8. Biologics Fill / Finish Services Market forCartridges in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.5.4.9. Biologics Fill / Finish Services Market forCartridges in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.6. Biologics Fill / Finish Services Marketfor Syringes, 2019-2030
14.6.1. Biologics Fill / Finish Services Market forSyringes, 2019-2030: Distribution by Scale of Operation
14.6.2. Biologics Fill / Finish Services Market forSyringes, 2019-2030: Distribution by Type of Biologic
14.6.3. Biologics Fill / Finish Services Market forSyringes, 2019-2030: Distribution by Therapeutic Area
14.6.4. Biologics Fill / Finish Services Market forSyringes, 2019-2030: Distribution by Geographical Region
14.6.4.1. Biologics Fill / Finish Services Market forSyringes in North America, 2019-2030: Distribution by Scale of Operation
14.6.4.2. Biologics Fill / Finish Services Market forSyringes in North America, 2019-2030: Distribution by Type of Biologic
14.6.4.3. Biologics Fill / Finish Services Market forSyringes in North America, 2019-2030: Distribution by Therapeutic Area
14.6.4.4. Biologics Fill / Finish Services Market forSyringes in Europe, 2019-2030: Distribution by Scale of Operation
14.6.4.5. Biologics Fill / Finish Services Market forSyringes in Europe, 2019-2030: Distribution by Type of Biologic
14.6.4.6. Biologics Fill / Finish Services Market forSyringes in Europe, 2019-2030: Distribution by Therapeutic Area
14.6.4.7. Biologics Fill / Finish Services Market forSyringes in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.6.4.8. Biologics Fill / Finish Services Market forSyringes in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.6.4.9. Biologics Fill / Finish Services Market forSyringes in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.7. Biologics Fill / Finish Services Marketfor Vials, 2019-2030
14.7.1. Biologics Fill / Finish Services Market forVials, 2019-2030: Distribution by Scale of Operation
14.7.2. Biologics Fill / Finish Services Market forVials, 2019-2030: Distribution by Type of Biologic
14.7.3. Biologics Fill / Finish Services Market forVials, 2019-2030: Distribution by Therapeutic Area
14.7.4. Biologics Fill / Finish Services Market forVials, 2019-2030: Distribution by Geographical Region
14.7.4.1. Biologics Fill / Finish Services Market forVials in North America, 2019-2030: Distribution by Scale of Operation
14.7.4.2. Biologics Fill / Finish Services Market forVials in North America, 2019-2030: Distribution by Type of Biologic
14.7.4.3. Biologics Fill / Finish Services Market forVials in North America, 2019-2030: Distribution by Therapeutic Area
14.7.4.4. Biologics Fill / Finish Services Market forVials in Europe, 2019-2030: Distribution by Scale of Operation
14.7.4.5. Biologics Fill / Finish Services Market forVials in Europe, 2019-2030: Distribution by Type of Biologic
14.7.4.6. Biologics Fill / Finish Services Market forVials in Europe, 2019-2030: Distribution by Therapeutic Area
14.7.4.7. Biologics Fill / Finish Services Market forVials in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.7.4.8. Biologics Fill / Finish Services Market forVials in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.7.4.9. Biologics Fill / Finish Services Market forVials in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
15. FUTURE GROWTH OPPORTUNITIES
15.1. Chapter Overview
15.2. Growing Biopharmaceutical Pipeline
15.3. Increase in Outsourcing Fill / FinishActivities
15.4. Rising Focus on Self-Administration
15.5. Advances in Aseptic Fill / FinishTechnologies
15.6. Growing Opportunities in theAsia-Pacific Region
16. CASE STUDY: ROBOTIC SYSTEMS IN FILL /FINISH OPERATIONS
16.1. Chapter Overview
16.2. Contract Service Providers: List ofFill / Finish Equipment
16.3. Role of Robotic Systems in Fill / Finish Operations
16.3.1. Types of Robots Used in PharmaceuticalOperations
16.3.2. Key Considerations for Selecting a RoboticSystem
16.3.3. Advantages of Robotic Systems
16.3.4. Disadvantages of Robotic Systems
16.4. Companies Providing Robots for Use inthe Pharmaceutical Industry
16.5. Concluding Remarks
17. CASE STUDY: READY-TO-USE PACKAGINGCOMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS
17.1. Chapter Overview
17.2. Role of Ready-to-Use PackagingComponents in Aseptic Fill / Finish Operations
17.2.1. Advantages of Ready-to-Use PackagingComponents
17.2.2. Disadvantages of Ready-to-Use PackagingComponents
17.3. Companies Providing Ready-to-UsePackaging Components
17.4. Concluding Remarks
18. CONCLUDING REMARKS
18.1. Chapter Overview
18.2. Key Takeaways
19. INTERVIEW TRANSCRIPTS
19.1 Chapter Overview
19.2 HALIX
19.2.1 Interview Transcript: Jos Vergeest,International Business Developer
19.3 IDT Biologika
19.3.1. Interview Transcript: Gregor Kawaletz,Chief Commercial Officer
19.4 oncomed manufacturing
19.4.1 Interview Transcript: Ales Sima,Business Development Manager
19.5. Syngene
19.5.1 Interview Transcript: PurushottamSingnurkar, Research Director and Head of Formulation Development
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES ANDORGANIZATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
